XL147 analogue

Catalog No. A10995

XL147 analogue是一种有效的,选择性的,口服可生物利用的I类磷脂酰肌醇3激酶(PI3K)小分子抑制剂,作用于PI3Kα/δ/γ,对PI3Kβ作用效果稍弱。具有潜在的抗肿瘤活性。
  • Yushi Hayashida, .et al. Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor, Int J Cancer, 2016, Aug 1;139(3):700-11 PMID: 26989815
Catalog Num A10995
M. Wt 448.5
Formula C21H16N6O2S2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 956958-53-5
Synonyms XL-147, SAR245408
SMILES CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4
XL147 analogue是一种有效的,选择性的,口服可生物利用的I类磷脂酰肌醇3激酶(PI3K)小分子抑制剂,作用于PI3Kα/δ/γ,对PI3Kβ作用效果稍弱。具有潜在的抗肿瘤活性。
Targets
Target Value
PI3KγIC50: 23nM
PI3KδIC50: 36nM
PI3KαIC50: 39nM
PI3KβIC50: 383nM
DNA-PKIC50: 4.75μM
Vps34IC50: 6.975μM
MEKIC50: >10μM
B-Raf/C-RafIC50: >10μM
mTORIC50: >15μM
In vitro (25°C) DMSO 3 mg/mL (6.68 mM)
Water Insoluble
Ethanol Insoluble
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 14 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 22.3 mL 111.48 mL 222.97 mL
0.5 mM 4.46 mL 22.3 mL 44.59 mL
1 mM 2.23 mL 11.15 mL 22.3 mL
5 mM 0.45 mL 2.23 mL 4.46 mL

*The above data is based on the productmolecular weight 448.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.